This episode’s Community Champion Sponsor is Augmedix. To learn how they are revolutionizing the electronic health record: CLICK HERE
---
Creating and maintaining strict infectious disease protocols for our frontline healthcare workers while caring for COVID-19 patients has been an ongoing challenge, with detrimental and deadly impact.
Our next guest has applied his company’s pre-existing technology to address this significant need for our nation’s health systems and its heroes.
Dr. Robert Hamilton, the Chief Scientific Officer for NovaSignal, shares how his company’s product, NovaGuide, helps providers assess their patients while minimizing exposure to the Coronavirus.
Additionally, Dr. Hamilton discusses the positive results of this work, which was recently published in conjunction with Mt. Sinai Hospital as well as where Dr. Hamilton sees the future of cloud computing and data analytics to assess brain health well beyond this current public health crisis.
Join us for this important and needed conversation as we continue to work together to safely battle and eliminate the Coronavirus pandemic.
Episode Highlights:
- History of how NovaSignal came to be
- How Robert’s team responded to the COVID-19 outbreak
- Why NovaSignal focused their energy and technology to address the pandemic
- NovaSignal’s COVID-19 partnership with Mount Sinai and early results
- Where Robert sees his technology being applied beyond the pandemic
About our Guest:
Dr. Robert Hamilton is the Co-Founder and Chief Scientific Officer at NovaSignal. He is an accomplished entrepreneur, engineer, and clinical researcher with a passion for innovative technologies in the area of brain health management. Robert is an expert in image/signal processing and machine learning, with extensive experience in cerebral blood flow, traumatic brain injury, stroke, and other neurological disorders.
During his tenure at the company, Robert has acted as principal investigator on federal grants and contracts totaling more than $25M from the Department of Defense, National Institutes of Health, and the National Science Foundation. Additionally, Dr. Hamilton has been invited to give several talks and presentations on entrepreneurship, technology development, and healthcare. He has achieved greater than 100 citations of his work in peer-reviewed publications and conferences and holds over 100 patent assets related to the core technology developed during his PhD studies.
In addition to his work at NovaSignal, Robert serves on the board of the Goggio Family Foundation (GFF). The foundation’s mission is to transform lives and strengthen communities by fostering innovation, creating knowledge, and promoting social progress. GFF provides grants in several program areas including community development, environmental preservation, and education. This aligns well with Robert’s passion for international collaboration, having worked in Malawi, Haiti, and China on brain health projects. Robert also serves on the UCLA Bioengineering Alumni Advisory Board.
Robert earned a B.A. in mathematics from the College of Idaho, B.S. in biomedical engineering from Washington University in St. Louis, and M.S. and Ph.D. degrees in biomedical engineering from the University of California, Los Angeles.
Links Supporting This Episode:
